Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »
Mar 1, 2009 (Vol. 29, No. 5)

TechNote: High-Throughput Kinase Selectivity Profiling

Bridging the Gulf between Compound Libraries and Rapid Discovery

  • Protein kinase-focused drug discovery efforts are escalating rapidly as research continues to elucidate and define the role of kinases in a growing list of diseases. To date, these research efforts have yielded eight FDA-approved small molecule kinase inhibitors with over 500 more in active development. While kinase inhibitors demonstrate great promise for disease treatment and management, target selectivity is a common challenge in drug development. 

    High-throughput screening in kinase inhibitor discovery is an effective platform for hit identification, compound annotation, and selectivity profiling. In the traditional kinase inhibitor discovery paradigm, however, a compound library is typically interrogated against a single kinase.

    The disadvantage with this approach is that it may overlook off-target interactions that may be important for understanding biological activity. Additionally, only a limited view of a library’s kinome-wide inhibition potential is provided, which may prevent identification of other therapeutically relevant interactions. 


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »